These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26370910)

  • 21. Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion protein.
    Cox GN; Smith DJ; Carlson SJ; Bendele AM; Chlipala EA; Doherty DH
    Exp Hematol; 2004 May; 32(5):441-9. PubMed ID: 15145212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of rhGH decorated by polyethylene glycol in rat in vivo].
    Jiang L; Cai YM; Zeng Y; Huang J; Chen ZM
    Yao Xue Xue Bao; 2009 May; 44(5):506-9. PubMed ID: 19618727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE
    Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats.
    Verhaeghe J; van Bree R; Van Herck E; Thomas H; Skottner A; Dequeker J; Mosekilde L; Einhorn TA; Bouillon R
    J Bone Miner Res; 1996 Nov; 11(11):1723-35. PubMed ID: 8915780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment with GH and IGF-I: additive effect on cortical bone mass but not on linear bone growth in female rats.
    Sundström K; Cedervall T; Ohlsson C; Camacho-Hübner C; Sävendahl L
    Endocrinology; 2014 Dec; 155(12):4798-807. PubMed ID: 25243853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Superlong-Acting Growth Hormone-Polypeptide Fusion for Growth Hormone Deficiency Treatment.
    Yang Z; Yao Q; Gong L; Zhang F; Sun J; Sun Y; Gao W
    Adv Healthc Mater; 2024 Feb; 13(5):e2302507. PubMed ID: 38030143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone inhibition of growth hormone release stimulated by a growth hormone secretagogue: studies in the rat and dog.
    Rigamonti AE; Cella SG; Giordani C; Bonomo SM; Giunta M; Sartorio A; Muller E
    Neuroendocrinology; 2006; 84(2):115-22. PubMed ID: 17106185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kidneys play a central role in the clearance of rhGH in rats.
    Vestergaard B; Thygesen P; Kreilgaard M; Fels JJ; Lykkesfeldt J; Agersø H
    Eur J Pharm Sci; 2016 Apr; 86():29-33. PubMed ID: 26946443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-terminal alanine-extended GLP-1/IgG-Fc fusion protein confers resistance to DPP-IV and reduces serum glucose level in db/db mice.
    Chung HS; Oh JY; Yoo SB; Lee SM; Cho HS
    Regul Pept; 2011 Oct; 170(1-3):1-3. PubMed ID: 21621561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pegylated long-acting human growth hormone is well-tolerated in healthy subjects and possesses a potential once-weekly pharmacokinetic and pharmacodynamic treatment profile.
    Rasmussen MH; Bysted BV; Anderson TW; Klitgaard T; Madsen J
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3411-7. PubMed ID: 20427496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence studies of omnitrope, the first biosimilar/rhGH follow-on protein: two comparative phase 1 randomized studies and population pharmacokinetic analysis.
    Stanhope R; Sörgel F; Gravel P; Pannatier Schuetz YB; Zabransky M; Muenzberg M
    J Clin Pharmacol; 2010 Nov; 50(11):1339-48. PubMed ID: 20173088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of a single dose of recombinant human growth hormone after subcutaneous administration by jet-injection: comparison with conventional needle-injection.
    Verhagen A; Ebels JT; Dogterom AA; Jonkman JH
    Eur J Clin Pharmacol; 1995; 49(1-2):69-72. PubMed ID: 8751024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human growth hormone expressed in tobacco cells as an arabinogalactan-protein fusion glycoprotein has a prolonged serum life.
    Xu J; Okada S; Tan L; Goodrum KJ; Kopchick JJ; Kieliszewski MJ
    Transgenic Res; 2010 Oct; 19(5):849-67. PubMed ID: 20135224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-dissolving micropiles for the percutaneous absorption of recombinant human growth hormone in rats.
    Ito Y; Ohashi Y; Shiroyama K; Sugioka N; Takada K
    Biol Pharm Bull; 2008 Aug; 31(8):1631-3. PubMed ID: 18670103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEG-rhGH therapy for small for gestational age rats and effects on their metabolic parameters.
    Xu Y; Ke H; Liang L; Wang X; Pei J; Du L
    Horm Res Paediatr; 2011; 76(1):35-43. PubMed ID: 21389689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand-receptor fusions.
    Ferrandis E; Pradhananga SL; Touvay C; Kinoshita C; Wilkinson IR; Stafford K; Wu Z; Strasburger CJ; Sayers JR; Artymiuk PJ; Ross RJ
    Clin Sci (Lond); 2010 Aug; 119(11):483-91. PubMed ID: 20597861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic administration of recombinant human growth hormone induces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats.
    Minami S; Kamegai J; Sugihara H; Hasegawa O; Wakabayashi I
    Endocrinology; 1992 Jul; 131(1):247-53. PubMed ID: 1612002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained delivery of human growth hormone from a novel gel system: SABER.
    Okumu FW; Dao le N; Fielder PJ; Dybdal N; Brooks D; Sane S; Cleland JL
    Biomaterials; 2002 Nov; 23(22):4353-8. PubMed ID: 12219825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of rhEPO-L-Fc fusion protein and analysis of its bioactivity and pharmacokinetics].
    Zhu Q; Huang Z; Huang Y; Qin Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1874-9. PubMed ID: 19256332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a Transnasal Delivery System for Recombinant Human Growth Hormone (rhGH): Effects of the Concentration and Molecular Weight of Poly-L-arginine on the Nasal Absorption of rhGH in Rats.
    Kawashima R; Uchida M; Yamaki T; Ohtake K; Hatanaka T; Uchida H; Ueda H; Kobayashi J; Morimoto Y; Natsume H
    Biol Pharm Bull; 2016; 39(3):329-35. PubMed ID: 26725528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.